Create Your Own Business Intelligence Website
Input the stock code or the company name     Search  

<06185.HK> - CanSino Biologics Inc.

 
 Basic Datum
Company name Lot P/E P/B EPS DPS
CANSINOBIO 200 -3.57 0.9479 -6.5882 0.0
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
01-12 CLSA  CANSINOBIO 買入29
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2022-09-13 康希諾生物(6185)近期推出霧化吸入使用的5型腺病毒載體(Ad5-nCoV)預防新冠肺炎疫苗,最近獲內地藥監局納入緊急使用範圍。因疫情邁向流感化下,新疫苗可作加強劑使用。
 
2022-09-13 康希諾生物「克威莎霧優」新冠肺炎疫苗可支持滅活及其他疫苗,作為第四針甚至第五針加強劑去應用。新疫苗在激發體液免疫及細胞免疫之外,亦實現誘導黏膜免疫,可調動肺部免疫體系,可進一步加強預防功能,因此有助日後用同一思路作更多產品開發。至於其開發的mRNA新冠疫苗產品,則已進入臨床二期階段,他形容進展非常順利。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
CANSINOBIO 05-08 11:26 20.15  20.15  ∞%
≫More
 
 

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved